Novo Nordisk Doubles Down: Lawsuit Against Hims & Hers Continues Despite 'Wegovy Pill' Plans Scrapped

Weight-Loss Drug Wars Escalate: Novo Nordisk Sues Hims & Hers Over Compounded Semaglutide

Beyond the Touchdowns: When Politics Takes Center Stage at the Super Bowl

Hims & Hers' Super Bowl Cancer Test Ad Sparks Heated Debate Over Reliability and Ethics

Hims & Hers Bucks the Trend: A Bold Super Bowl Play in a Sea of Caution

A Tale of Two Pivots: Hims & Hers Retreats on Weight-Loss Pill, Washington Post Sees Editorial Shift

The Weight-Loss Revolution: Telehealth Giant Hims & Hers Dives into the GLP-1 Market

Hims & Hers Hits the Brakes: Generic Wegovy Plans Abandoned Amidst GLP-1 Market Shifts

The Weight of Expectation: Hims & Hers Eyes a Major Leap into the GLP-1 Arena

Oscar Health: The Next Healthcare Moonshot Poised for Explosive Growth, Threatening a Short Squeeze

FDA Unleashes Scrutiny: Telehealth Giants Like Hims Under Fire for 'Misleading' Drug Ads